Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Thomas Charles Heineman

Chief Medical Officer at Oncolytics Biotech Inc (ONCY)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-17.9%
vs. S&P 500-28.0%
Beat the market0%
Paper profit on buys−$3K
Total bought / sold$10K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Feb 13SEC ONCYOncolytics Biotech Inc Buy 12,132282,818 held (+4%) $0.83 $10K -32.5%
  • Buy

    Chief Medical Officer Thomas Charles Heineman bought $10K of ONCY at $0.83 — first open-market purchase in our records.